No Detail Found!

Examination of quality of life in patients using exenatide with different dimensions

Author(s)
Siddika Ersoy Department of Nursing Isparta City Hospital, Isparta, Turkey.
Ismail Hakki Ersoy Department of Internal Medicine, Isparta City Hospital,Isparta, Turkey.
Sukran Ozkahraman-Koc Department of Midwifery, Suleyman Demirel University,Isparta,Turkey.
Abstract
Objective: To investigate the effects of exenatide treatment on type-2 diabetes mellitus patients' quality of life. Methods: The cross-sectional study was conducted from March 1 to June 30, 2019, after approval from Suleyman Demirel University, Isparta, Turkey, and comprised type 2 diabetes mellitus patients of either gender under exenatide treatment. Data was collected using a questionnaire during face-to-face interview and included sociodemographic and clinical information along with the World Health Organisation-5 well-being index, the obesity awareness and insight scale, the obesity-specific quality of life scale and the coping orientation to problems experienced-brief inventory. Data was analysed using SPSS 22. Results: Of the 146 patients, 82(56.2%) were female. The overall mean age was 50.6±11.5 years, mean duration of diabetes was 7.4±4.3 years, and mean exenatide use was 9.1±6.6 months. The most common reason cited in favour of exenatide was related to weight-loss 121(82.9%). The patients scored the highest score on the 'Awareness' subscale of the obesity awareness scale 29.54±5.42. Conclusion: Exenatide use was effective in improving quality of life, and weight-loss was considered a secondary gain by the diabetics.
Publication Details
Page(s) 817-821
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 72, Issue: 5, Year: 2022

Request the full text from PASTIC

Keywords
Diabetes Mellitus, Quality of life, Patients, Exenatide
0

Citations

0

Downloads

147

Views